(Total Views: 223)
Posted On: 12/23/2019 9:26:31 AM
Post# of 63821
$ APOP 2.20 GREAT NEWS Approval For U.S. Clinical Trial
All Content and Data provided by Third-Parties — Terms of Use
BRIEF-Cellect Biotechnology Receives Approval For U.S. Clinical Trial
REUTERS 7:17 AM ET 12/23/2019
Symbol Last Price Change
APOP 2.2down 0 (0%)
QUOTES AS OF 03:56:55 PM ET 12/20/2019
Dec 23 (Reuters) - Cellect Biotechnology Ltd(APOP):
* CELLECT BIOTECHNOLOGY RECEIVES APPROVAL FOR U.S. CLINICAL TRIAL
* CELLECT - GOT APPROVAL TO BEGIN TRIAL IN U.S. TO EVALUATE SAFETY, TOLERABILITY OF APOGRAFT TECHNOLOGY FOR HAPLOIDENTICAL BONE MARROW TRANSPLANTATIONS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
(c) Copyright Thomson Reuters 2019. Click For Restrictions - https://agency.reuters.com/en/copyright.html
APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP
All Content and Data provided by Third-Parties — Terms of Use
BRIEF-Cellect Biotechnology Receives Approval For U.S. Clinical Trial
REUTERS 7:17 AM ET 12/23/2019
Symbol Last Price Change
APOP 2.2down 0 (0%)
QUOTES AS OF 03:56:55 PM ET 12/20/2019
Dec 23 (Reuters) - Cellect Biotechnology Ltd(APOP):
* CELLECT BIOTECHNOLOGY RECEIVES APPROVAL FOR U.S. CLINICAL TRIAL
* CELLECT - GOT APPROVAL TO BEGIN TRIAL IN U.S. TO EVALUATE SAFETY, TOLERABILITY OF APOGRAFT TECHNOLOGY FOR HAPLOIDENTICAL BONE MARROW TRANSPLANTATIONS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)
(c) Copyright Thomson Reuters 2019. Click For Restrictions - https://agency.reuters.com/en/copyright.html
APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP APOP
(0)
(0)
I ONLY POST WHAT I PLAY
